Medicare payment | Annual payment, mean ± STD (median, Q1-Q3) | Difference (High-Low) | p-value | |
---|---|---|---|---|
High (N = 22853) | Low (N = 23929) | |||
PSA tests | 21.04 ± 18.35 (13.18, 12.95–26.13) | 13.51 ± 17.95 (12.95, 0.00–26.13) | 7.53 | <0.001 |
Biopsies | 3.05 ± 23.85 (0.00, 0.00–0.00) | 2.86 ± 24.30 (0.00, 0.00–0.00) | 0.19 | 0.022 |
Ultrasounds | 1.76 ± 10.22 (0.00, 0.00–0.00) | 1.49 ± 9.53 (0.00, 0.00–0.00) | 0.27 | 0.001 |
Imaging | 1.29 ± 17.29 (0.00, 0.00–0.00) | 1.00 ± 14.59 (0.00, 0.00–0.00) | 0.29 | 0.109 |
Radiation | 52.87 ± 715.37 (0.00, 0.00–0.00) | 35.78 ± 576.59 (0.00, 0.00–0.00) | 17.09 | 0.011 |
Radical prostatectomy | 2.39 ± 139.61 (0.00, 0.00–0.00) | 1.60 ± 76.29 (0.00, 0.00–0.00) | 0.79 | 0.116 |
Androgen deprivation therapy | 5.49 ± 77.92 (0.00, 0.00–0.00) | 5.03 ± 74.10 (0.00, 0.00–0.00) | 0.46 | 0.597 |
E&M services for prostate cancer | 2.83 ± 26.24 (0.00, 0.00–0.00) | 2.25 ± 25.25 (0.00, 0.00–0.00) | 0.58 | 0.026 |
E&M services from urologists | 35.39 ± 70.54 (0.00, 0.00–52.84) | 34.78 ± 71.51 (0.00, 0.00–52.28) | 0.61 | 0.353 |
Prostate cancer associated payment | 90.72 ± 802.43 (13.18, 12.95–26.13) | 63.51 ± 642.59 (12.95, 0.00–26.13) | 27.21 | <0.001 |
Overall Medicare payment | 8974.60 ± 14138.80 (3696.48, 1577.69–10282.41) | 8983.52 ± 14040.08 (3702.07, 1526.73–10360.21) | −8.92 | 0.249 |
Adjusted annual payment - GLM model (95 % CI) | ||||
Prostate cancer associated payment | 80.63 (78.13–83.22) | 55.01 (53.34–56.73) | 25.62 | |
Overall Medicare payment | 8358.94 (8233.38–8486.42) | 8377.71 (8254.63–8502.64) | −18.77 |